World Of Taxonomy
0299-6220Level 3

NEMLUVIO (nemolizumab-ilto)

**Product type:** Human Prescription Drug

**Active ingredient:** NEMOLIZUMAB

**Strength:** 30 mg/100mg

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Subcutaneous

**Labeler:** Galderma Laboratories, L.P.

**Marketing category:** BLA (BLA761390)

**Pharmacologic class:** Interleukin-31 Receptor alpha Antagonist [EPC], Interleukin-31 Receptor alpha Antagonists [MoA]

GET/api/v1/systems/ndc_fda/nodes/0299-6220
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.